New research indicates that patients with kidney failure who receive care at for-profit dialysis facilities are less likely to be referred for kidney transplants than those receiving care at non-profit facilities. These findings appear in the Clinical Journal of the American Society of Nephrology (CJASN).
“Our study offers insight into the practice patterns related to referral for transplantation, start of the transplant evaluation at the transplant centre, and placement on the national deceased donor waiting list—but our study does not have detailed information about the mechanisms and reasons for these differences in referral between for-profit and non-profit facilities,” said Rachel E Patzer (Emory University School of Medicine, Atlanta, USA), who led the team conducting this research.
“The reasons for these differences in referral could be due to differences in patients’ health status that are not measured in our dataset, or they could be due to other unmeasured factors, such as limited time to educate or refer patients for transplant, or unconscious bias. Future research is still needed to better understand these mechanisms, such as through focus groups, and interviews with patients and care provider team members.”
Kidney transplantation is the optimal therapy for most patients with kidney failure. Many patients first initiate dialysis and are referred for a transplant by kidney specialists through dialysis facilities. The researchers note that previous studies have reported that patients treated at for-profit dialysis facilities are less likely than those treated at non-profit facilities to be placed on a transplant waiting list, and to receive a transplant. Little information is available concerning earlier steps in the process, however—namely, referrals and medical evaluations for transplantation.
To investigate, a team led by Patzer and Laura J McPherson (Emory University School of Medicine, Atlanta, USA) examined referral and evaluation data from all nine transplant centres in the South-eastern US states—Georgia, North Carolina, and South Carolina—as well as information from the United States Renal Data System.
The analysis included 33,651 patients with kidney failure who initiated dialysis in the Southeast from 2012 to 2016. Some 85% of patients received dialysis treatments at for-profit facilities, and 15% were treated at non-profit facilities. A total of 44% of patients were referred for transplant during the four-year study period. After adjustments, patients at for-profit facilities were 16% less likely to receive a referral than patients at non-profit facilities. Rates of starting medical evaluations within six months of referral and placing patients on a waiting list within six months of evaluations did not meaningfully differ between the groups.
An editorial accompanying the report notes that “the early steps in transplant access remain frustratingly opaque, indicating the ongoing need to address long-standing disparities and ensure equity in treatment options for patients with kidney failure”.
